🇺🇸 FDA
Patent

US 9574191

Selective inhibition of polyglutamine protein expression

granted A61KA61K31/713A61K38/1709

Quick answer

US patent 9574191 (Selective inhibition of polyglutamine protein expression) held by The Board of Regents of the University of Texas System expires Mon Feb 16 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Feb 21 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 16 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
2
CPC classes
A61K, A61K31/713, A61K38/1709